Delivering mitochondrial health
Abliva will attend the digital Swiss Nordic Bio 2021. "Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry. The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof. The conference is organised by the Nordic countries in […]
Abliva will participate at the virtual BioStock Live on 9 March 2021. CEO Ellen Donnelly will be presenting the company. More information to come.
Abliva will participate at Aktiespararna's Aktiedagen (virtual) on 16 March 2021. CEO Ellen Donnelly will be presenting the company at 6.30 p.m. CET.
Abliva will participate at the virtual European Biotech Investor Days, Hosted by Solebury Trout. CEO Ellen Donnelly will be presenting the company on 7 April 2021, at 06:30 p.m. CEST.
Abliva will participate at Redeye's seminar on ‘Drug development in orphan indications.’ CEO Ellen Donnelly will be presenting the company at 10:55 a.m. CEST. Follow link below for further details and live webcast.
CEO Ellen Donnelly will present the company at 1:20 p.m. CEST.
The US patient organization United Mitochondrial Disease Foundation (UMDF) is hosting its annual Mitochondrial Medicine Symposium, this year virtual, in June. Abliva will participate in the scientific sessions: Chief Medical Officer, Magnus Hansson, will constitute one of the panelists, on Friday 25 June, at 1:50 p.m. EST, in the Clinical Trials Panel #2 Discussion, together […]
Abliva will participate at Aktiespararna's Kvinnokvällen (Women's night) in Gothenburg, on 31 August 2021. CEO Ellen Donnelly will be presenting the company digitally, at 6 p.m. CEST. Follow the event live here: aktiespararna.se/tv/live
Now you can sign up for LHON Eye Society's 5 km Mito-race, either in Stockholm on 15 September, or the virtual one on 12 - 18 September. The event takes place in connection to the World Mitochondrial Disease Week (19 - 25 September).
Every year, during the third week of September, the World Mitochondrial Disease Week (WMDW) is being held. This global, important, and rapidly growing event was an initiative from patient organization International mito-patients (IMP).
Abliva would like to invite interested shareholders and investors to a fun and informal “Fireside Chat” with the company's CEO, Ellen Donnelly, and members of the Abliva team, in Stockholm (28 September) and Lund (29 September). After a long stretch of stringent travel restrictions and two-dimensional zoom presentations, we would like to invite Abliva shareholders […]
Abliva will attend the digital/hybrid event: 21st Annual Biotech in Europe Forum (BEF), on 7 - 8 October 2021.
